These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 27149406)
1. Ultrasound-Guided Laser Ablation Using Multidirectional-Firing Fiber for Papillary Thyroid Carcinoma: An Ex Vivo Study with Evaluation of Tumor Cell Viability. Lee J; Jung JH; Kim WW; Hwang SO; Park JY; Jeong JY; Kim C; Sohn IB; Lee H; Park HY Photomed Laser Surg; 2016 Jul; 34(7):300-4. PubMed ID: 27149406 [TBL] [Abstract][Full Text] [Related]
2. Ultrasound-guided percutaneous laser ablation of papillary thyroid microcarcinoma: a feasibility study on three cases with pathological and immunohistochemical evaluation. Valcavi R; Piana S; Bortolan GS; Lai R; Barbieri V; Negro R Thyroid; 2013 Dec; 23(12):1578-82. PubMed ID: 23978269 [TBL] [Abstract][Full Text] [Related]
4. Ultrasound-guided laser ablation of incidental papillary thyroid microcarcinoma: a potential therapeutic approach in patients at surgical risk. Papini E; Guglielmi R; Gharib H; Misischi I; Graziano F; Chianelli M; Crescenzi A; Bianchini A; Valle D; Bizzarri G Thyroid; 2011 Aug; 21(8):917-20. PubMed ID: 21595556 [TBL] [Abstract][Full Text] [Related]
5. Comparison of laser ablation using multidirectional and forward-firing fibers in breast cancer. Lee J; Jung JH; Kim WW; Moon SH; Jeong JH; Park JY; Jeong JY; Lee H; Sohn IB; Kim CH; Park HY Minim Invasive Ther Allied Technol; 2018 Oct; 27(5):292-299. PubMed ID: 29355057 [TBL] [Abstract][Full Text] [Related]
6. Percutaneous ultrasound-guided laser ablation is effective for treating selected nodal metastases in papillary thyroid cancer. Papini E; Bizzarri G; Bianchini A; Valle D; Misischi I; Guglielmi R; Salvatori M; Solbiati L; Crescenzi A; Pacella CM; Gharib H J Clin Endocrinol Metab; 2013 Jan; 98(1):E92-7. PubMed ID: 23150695 [TBL] [Abstract][Full Text] [Related]
7. Comparison of laser ablation using multidirectional and forward-firing fiber in human thyroid gland: experimental study. Park HY; Choi HH; Lee JJ; Hwang SO; Jung JH; Sohn IB; Lee H; Kim WW Otolaryngol Head Neck Surg; 2013 Nov; 149(5):689-91. PubMed ID: 23929758 [TBL] [Abstract][Full Text] [Related]
8. Percutaneous laser ablation for treatment of locally recurrent papillary thyroid carcinoma <15 mm. Zhou W; Zhang L; Zhan W; Jiang S; Zhu Y; Xu S Clin Radiol; 2016 Dec; 71(12):1233-1239. PubMed ID: 27554615 [TBL] [Abstract][Full Text] [Related]
9. Locoregional control of recurrent papillary thyroid carcinoma by ultrasound-guided percutaneous microwave ablation: A prospective study. Yue W; Chen L; Wang S; Yu S Int J Hyperthermia; 2015 Jun; 31(4):403-8. PubMed ID: 25792224 [TBL] [Abstract][Full Text] [Related]
10. Treatment of Metastatic Lymph Nodes in the Neck from Papillary Thyroid Carcinoma with Percutaneous Laser Ablation. Mauri G; Cova L; Ierace T; Baroli A; Di Mauro E; Pacella CM; Goldberg SN; Solbiati L Cardiovasc Intervent Radiol; 2016 Jul; 39(7):1023-30. PubMed ID: 26911732 [TBL] [Abstract][Full Text] [Related]
11. Single-Fiber Laser Ablation in Treating Selected Metastatic Lymph Nodes of Papillary Thyroid Carcinoma and Benign Cold Thyroid Nodules-Preliminary Results. Guo Y; Li Z; Wang S; Liao X; Li C Lasers Surg Med; 2020 Jun; 52(5):408-418. PubMed ID: 31489681 [TBL] [Abstract][Full Text] [Related]
12. Hyalinizing trabecular tumor masquerading as papillary thyroid carcinoma on fine-needle aspiration. Howard BE; Gnagi SH; Ocal IT; Hinni ML ORL J Otorhinolaryngol Relat Spec; 2013; 75(6):309-13. PubMed ID: 24107636 [TBL] [Abstract][Full Text] [Related]
13. Pretransplant Thyroid Findings in Patients With End-Stage Renal Disease. Yılmaz Akçay E; Tepeoğlu M; Özdemir BH; Özgün G; Kazancı S; Haberal M Exp Clin Transplant; 2016 Nov; 14(Suppl 3):67-70. PubMed ID: 27805516 [TBL] [Abstract][Full Text] [Related]
14. Predictive factors for extrathyroidal extension of papillary thyroid carcinoma based on preoperative sonography. Lee CY; Kim SJ; Ko KR; Chung KW; Lee JH J Ultrasound Med; 2014 Feb; 33(2):231-8. PubMed ID: 24449725 [TBL] [Abstract][Full Text] [Related]
15. Thyroid ablation with 1.1 GBq (30 mCi) iodine-131 in patients with papillary thyroid carcinoma at intermediate risk for recurrence. Rosário PW; Calsolari MR Thyroid; 2014 May; 24(5):826-31. PubMed ID: 24283207 [TBL] [Abstract][Full Text] [Related]
16. Utility of BRAF mutation detection in fine-needle aspiration biopsy samples read as "suspicious for papillary thyroid carcinoma". Jara SM; Bhatnagar R; Guan H; Gocke CD; Ali SZ; Tufano RP Head Neck; 2015 Dec; 37(12):1788-93. PubMed ID: 24989827 [TBL] [Abstract][Full Text] [Related]
17. The value of ultrasound guided laser ablation in papillary thyroid recurrence carcinoma: A retrospective, single center study from China. Yong-Ping L; Juan Z; Li JW; Qi HH; Liu JP; Zhao YF; Liu WG; Zhang XH; Zhou P Front Endocrinol (Lausanne); 2022; 13():946966. PubMed ID: 36157471 [TBL] [Abstract][Full Text] [Related]
18. Value of immunohistochemistry in the detection of BRAF(V600E) mutations in fine-needle aspiration biopsies of papillary thyroid carcinoma. Zimmermann AK; Camenisch U; Rechsteiner MP; Bode-Lesniewska B; Rössle M Cancer Cytopathol; 2014 Jan; 122(1):48-58. PubMed ID: 24039206 [TBL] [Abstract][Full Text] [Related]
19. [The frequency of malignant disease in cytological group of suspected cancer (ultrasound-guided fine-needle aspiration biopsy of nonpalpable thyroid nodules)]. Miseikyte-Kaubriene E; Ulys A; Trakymas M Medicina (Kaunas); 2008; 44(3):189-94. PubMed ID: 18413985 [TBL] [Abstract][Full Text] [Related]
20. Size discrepancy between sonographic and pathological evaluation of solitary papillary thyroid carcinoma. Bachar G; Buda I; Cohen M; Hadar T; Hilly O; Schwartz N; Shpitzer T; Segal K Eur J Radiol; 2013 Nov; 82(11):1899-903. PubMed ID: 23948454 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]